...
首页> 外文期刊>Clinical ophthalmology >Effects of VEGF Inhibitor Conbercept on Corneal Neovascularization Following Penetrating Keratoplasty in Rabbit Model
【24h】

Effects of VEGF Inhibitor Conbercept on Corneal Neovascularization Following Penetrating Keratoplasty in Rabbit Model

机译:VEGF抑制剂Conbercept对兔模型穿透角膜术后角膜新生血管的影响

获取原文
           

摘要

Purpose: To evaluate the effects of the vascular endothelial growth factor inhibitor conbercept (KH902) on corneal neovascularization and wound healing following penetrating keratoplasty in rabbits. Methods: Conbercept was administered to New Zealand white rabbits through topical and subconjunctival routes. Corneal neovascularization and wound healing were examined by slit-lamp photography and histological analyses. The expressions of vascular endothelial growth factor inhibitor, α-smooth muscle actin, and keratocan in the corneal grafts were measured by real-time quantitative polymerase chain reaction (RT-qPCR). Results: The anterior segment photographs demonstrated that corneal neovascularization started in the 2nd week. In the 4th week, histologically, the superficial corneal stroma layer showed disordered arrangement, and there were large numbers of dense inflammatory cells and blood vessels in the stroma layer. Vascular endothelial growth factor in the experimental groups was significantly decreased at all time points compared with the control group (both P = 0.001). Expression of α-smooth muscle actin in corneal grafts demonstrated an increase in time even it was lower in experimental groups, but the difference was not statistically significant (P equaled to 0.507 and 0.723, respectively). There were no significant differences with the expression of keratocan in all groups except that it significantly declined at the 4th week as to the second week in all groups and P values were 0.022, 0.020 and 0.014 in control (C), topical (E1), and subconjunctival (E2) group, respectively. Conclusion: The study found that conbercept inhibited the formation of corneal neovascularization without affecting keratocan-mediated corneal wound healing and there were no significant differences between topical administration of different doses of conbercept on the rabbit corneal neovascularization after penetrating keratoplasty in this study.
机译:目的:评估血管内皮生长因子抑制剂Conbercept(KH902)对兔渗透角膜术后角膜新血管形成和伤口愈合的影响。方法:Conbercept通过局部和子局的途径向新西兰白兔施用。通过狭缝灯的摄影和组织学分析检查角膜新血管形成和伤口愈合。通过实时定量聚合酶链反应(RT-QPCR)测量血管内皮生长因子抑制剂,α-平滑肌肌动蛋白和角膜移植物中的角蛋白的表达。结果:前段照片表明,角膜新生血管在第二周开始。在第4周,组织学上,浅表角膜基质层显示出无序排列,并且在基质层中存在大量的致密炎症细胞和血管。与对照组相比,实验组中的血管内皮生长因子在所有时间点上显着降低(P = 0.001)。 α-平滑肌肌动蛋白在角膜移植物中的表达表明,即使在实验组中较低,甚至均较低,但差异没有统计学意义(P分别等于0.507和0.723)。除了在所有群体中的第二周的第4周明显下降,P值在402,0.020%和0.014中,局部(c),局部(e1),局部(e1),术后第4周明显下降,概念性差异无显着差异。分别和亚细胞增殖(E2)组。结论:该研究发现,Conbercept抑制了角膜内血管形成的形成而不影响角膜蛋白介导的角膜伤口愈合,并且在本研究中渗透角膜形形术后兔角膜新血管中的不同剂量Conbercept局部施用无显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号